ClinVar Miner

Submissions for variant NM_000166.6(GJB1):c.148T>C (p.Ser50Pro)

dbSNP: rs913934445
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000493545 SCV000582848 likely pathogenic not provided 2017-05-22 criteria provided, single submitter clinical testing A variant that is likely pathogenic has been identified in the GJB1 gene. The S50P variant has been previously reported in two families with a clinical diagnosis of axonal CMT (Latour et al., 1997). The S50P variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The S50P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in nearby residues (S49P/Y, F51L, C53S/Y) have been reported in the Human Gene Mutation Database in association with CMT (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded
Athena Diagnostics Inc RCV000518090 SCV000613477 uncertain significance not specified 2016-12-02 criteria provided, single submitter clinical testing
Invitae RCV001856974 SCV002184184 uncertain significance Charcot-Marie-Tooth Neuropathy X 2021-04-20 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 10732813). ClinVar contains an entry for this variant (Variation ID: 430122). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with proline at codon 50 of the GJB1 protein (p.Ser50Pro). The serine residue is moderately conserved and there is a moderate physicochemical difference between serine and proline.
Inherited Neuropathy Consortium RCV000789248 SCV000928600 uncertain significance Charcot-Marie-Tooth disease no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.